Cargando…
Maternal and fetal serum concentrations of magnesium after administration of a 6‐g bolus dose of magnesium sulfate (MgSO(4) ) to women with imminent preterm delivery
INTRODUCTION: Magnesium sulfate is used world‐wide to treat pregnant women at imminent risk of preterm delivery in order to protect the brain of the premature infant. Previous research has shown that magnesium sulfate decreases the risk of cerebral palsy by ~30% in infants born preterm. Despite this...
Autores principales: | Jonsdotter, Andrea, Rocha‐Ferreira, Eridan, Hagberg, Henrik, Carlsson, Ylva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564565/ https://www.ncbi.nlm.nih.gov/pubmed/35501953 http://dx.doi.org/10.1111/aogs.14372 |
Ejemplares similares
-
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth
por: Hellström, Sara, et al.
Publicado: (2023) -
Effect of Magnesium Salt (MgCl(2) and MgSO(4)) on the Microstructures and Properties of Ground Granulated Blast Furnace Slag (GGBFS)-Based Geopolymer
por: Zhang, Kun, et al.
Publicado: (2022) -
Benefits of using magnesium sulphate (MgSO(4)) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria
por: Okereke, Ekechi, et al.
Publicado: (2012) -
Does Antenatal MgSO
(4)
Administration to the Mother in the Event of Imminent Premature Birth Reduce the Occurrence of Infantile Cerebral Palsy in the Child? –
An Umbrella Review
por: Binder, Charlotte, et al.
Publicado: (2023) -
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
por: Bouet, Pierre-Emmanuel, et al.
Publicado: (2015)